Longboard Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Longboard Pharmaceuticals

03/08/2023 21:55

* Longboard Pharmaceuticals Inc  LBPH.OQ  reported a
quarterly
adjusted loss of 65 cents​​ per share for the quarter ended in
June. The mean expectation of seven analysts for the quarter was
for a loss of 60 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Longboard Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 65 cents​.
    * The mean earnings estimate of analysts had fallen by
about 2.6%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Longboard Pharmaceuticals Inc shares had fallen by 2.6%
this
quarter and gained 119.3% so far this year.
    * The company reported a quarterly loss of $15 million.
    * Wall Street's median 12-month price target for Longboard
Pharmaceuticals Inc is $16.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 3 at 08:54 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.60          -0.65          Missed
 Mar. 31 2023      -0.57          -0.56          Beat
 Dec. 31 2022      -0.69          -0.66          Beat
 Sep. 30 2022      -0.64          -0.68          Missed